Stock Analysts’ Updated EPS Estimates for May 26th (ABVX, ALAB, AMBA, ATYM, BBIO, BCML, BHVN, BOY, BP, BRZE)

Stock Analysts’ updated eps estimates for Tuesday, May 26th:

Abivax (NASDAQ:ABVX) had its market outperform rating reissued by analysts at Citizens Jmp. Citizens Jmp currently has a $131.00 price target on the stock.

Astera Labs (NASDAQ:ALAB) was downgraded by analysts at Northland Securities from an outperform rating to a market perform rating.

Ambarella (NASDAQ:AMBA) had its buy rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $115.00 price target on the stock.

Atalaya Mining (LON:ATYM) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a GBX 1,090 target price on the stock.

BridgeBio Pharma (NASDAQ:BBIO) was downgraded by analysts at Raymond James Financial, Inc. from an outperform rating to a market perform rating.

Bay Commercial Bank (NASDAQ:BCML) had its neutral rating reiterated by analysts at DA Davidson. DA Davidson currently has a $34.00 target price on the stock.

Biohaven (NYSE:BHVN) had its neutral rating reaffirmed by analysts at HC Wainwright. HC Wainwright currently has a $10.00 target price on the stock.

Bodycote (LON:BOY) had its buy rating reissued by analysts at Deutsche Bank Aktiengesellschaft. Deutsche Bank Aktiengesellschaft currently has a GBX 835 price target on the stock.

BP (LON:BP) had its buy rating reissued by analysts at Royal Bank Of Canada.

Braze (NASDAQ:BRZE) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $30.00 price target on the stock.

Webull (NASDAQ:BULL) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $12.00 target price on the stock.

Cigna Group (NYSE:CI) had its equal weight rating reissued by analysts at Barclays PLC. The firm currently has a $304.00 price target on the stock, down from their previous price target of $310.00.

Cingulate (NASDAQ:CING) had its buy rating reiterated by analysts at HC Wainwright. They currently have a $20.00 price target on the stock.

Corbus Pharmaceuticals (NASDAQ:CRBP) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $40.00 price target on the stock.

Creo Medical Group (LON:CREO) had its house stock rating reiterated by analysts at Shore Capital Group Ltd. They currently have a GBX 40 target price on the stock.

Salesforce (NYSE:CRM) had its buy rating reissued by analysts at BTIG Research. They currently have a $255.00 target price on the stock.

CVS Group (LON:CVSG) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 2,000 target price on the stock.

Cranswick (LON:CWK) had its hold rating reaffirmed by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 5,770 target price on the stock.

Deutsche Lufthansa (OTCMKTS:DLAKY) was downgraded by analysts at Morgan Stanley from an equal weight rating to an underweight rating.

Elastic (NYSE:ESTC) had its buy rating reissued by analysts at Rosenblatt Securities. The firm currently has a $110.00 price target on the stock.

Evommune (NYSE:EVMN) had its buy rating reiterated by analysts at HC Wainwright. The firm currently has a $50.00 price target on the stock.

Expand Energy (NASDAQ:EXE) had its equal weight rating reaffirmed by analysts at Barclays PLC. Barclays PLC currently has a $110.00 target price on the stock, down from their previous target price of $127.00.

Eagle Eye Solutions Group (LON:EYE) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 660 target price on the stock.

Franchise Brands (LON:FRAN) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 185 price target on the stock.

Genuit Group (LON:GEN) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 332 price target on the stock.

Gossamer Bio (NASDAQ:GOSS) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $5.00 price target on the stock.

Helical (LON:HLCL) had its buy rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 270 target price on the stock.

Humacyte (NASDAQ:HUMA) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $3.00 price target on the stock.

Intel (NASDAQ:INTC) was downgraded by analysts at Northland Securities from an outperform rating to a market perform rating.

Innoviva (NASDAQ:INVA) had its buy rating reiterated by analysts at BTIG Research. BTIG Research currently has a $42.00 target price on the stock.

Kingfisher (LON:KGF) had its hold rating reiterated by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 291 price target on the stock.

LifeMD (NASDAQ:LFMD) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $10.00 price target on the stock.

MongoDB (NASDAQ:MDB) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $385.00 target price on the stock.

M.T.I Wireless Edge (LON:MWE) had its house stock rating reiterated by analysts at Shore Capital Group Ltd. The firm currently has a GBX 100 target price on the stock.

Neonc Technologies (NASDAQ:NTHI) had its buy rating reissued by analysts at BTIG Research. They currently have a $15.00 price target on the stock.

Oncolytics Biotech (NASDAQ:ONCY) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $10.00 target price on the stock.

Oxford Nanopore Technologies (LON:ONT) had its outperform rating reissued by analysts at Royal Bank Of Canada. They currently have a GBX 225 target price on the stock.

Poolbeg Pharma (LON:POLB) had its house stock rating reaffirmed by analysts at Shore Capital Group Ltd.

Praxis Precision Medicines (NASDAQ:PRAX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $1,245.00 price target on the stock.

Sionna Therapeutics (NASDAQ:SION) had its market outperform rating reaffirmed by analysts at Citizens Jmp. Citizens Jmp currently has a $63.00 target price on the stock.

Semtech (NASDAQ:SMTC) was downgraded by analysts at Northland Securities from an outperform rating to a market perform rating.

Millicom International Cellular (NASDAQ:TIGO) was downgraded by analysts at UBS Group AG from a buy rating to a neutral rating. They currently have $90.00 price target on the stock.

Telos (NASDAQ:TLS) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $6.00 target price on the stock.

Uber Technologies (NYSE:UBER) had its buy rating reiterated by analysts at DA Davidson. DA Davidson currently has a $107.00 price target on the stock.

Ultimate Products (LON:ULTP) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Velocity Composites (LON:VEL) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 40 target price on the stock.

VEON (NASDAQ:VEON) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.

Vontier (NYSE:VNT) was downgraded by analysts at Argus from a buy rating to a hold rating.

Vodafone Group (NASDAQ:VOD) was downgraded by analysts at Bank of America Corporation from a neutral rating to an underperform rating. The firm currently has $13.13 price target on the stock.

Workiva (NYSE:WK) had its overweight rating reiterated by analysts at Stephens. The firm currently has a $68.00 price target on the stock.